These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 24400229)
1. The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancer. Elkahwaji JE Res Rep Urol; 2012 Dec; 5():1-10. PubMed ID: 24400229 [TBL] [Abstract][Full Text] [Related]
2. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433 [TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory drugs, antioxidants, and prostate cancer prevention. Bardia A; Platz EA; Yegnasubramanian S; De Marzo AM; Nelson WG Curr Opin Pharmacol; 2009 Aug; 9(4):419-26. PubMed ID: 19574101 [TBL] [Abstract][Full Text] [Related]
4. A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression. Simons BW; Durham NM; Bruno TC; Grosso JF; Schaeffer AJ; Ross AE; Hurley PJ; Berman DM; Drake CG; Thumbikat P; Schaeffer EM J Pathol; 2015 Feb; 235(3):478-89. PubMed ID: 25348195 [TBL] [Abstract][Full Text] [Related]
5. Dying for love: Perimenopausal degeneration of vaginal microbiome drives the chronic inflammation-malignant transformation of benign prostatic hyperplasia to prostatic adenocarcinoma. Reece AS Med Hypotheses; 2017 Apr; 101():44-47. PubMed ID: 28351489 [TBL] [Abstract][Full Text] [Related]
6. Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention. Nickel JC; Roehrborn CG; Castro-Santamaria R; Freedland SJ; Moreira DM J Urol; 2016 Nov; 196(5):1493-1498. PubMed ID: 27378134 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of prostatitis in autopsied prostates--is chronic inflammation more associated with benign prostatic hyperplasia or cancer? Delongchamps NB; de la Roza G; Chandan V; Jones R; Sunheimer R; Threatte G; Jumbelic M; Haas GP J Urol; 2008 May; 179(5):1736-40. PubMed ID: 18343414 [TBL] [Abstract][Full Text] [Related]
9. Prostate carcinogenesis and inflammation: emerging insights. Palapattu GS; Sutcliffe S; Bastian PJ; Platz EA; De Marzo AM; Isaacs WB; Nelson WG Carcinogenesis; 2005 Jul; 26(7):1170-81. PubMed ID: 15498784 [TBL] [Abstract][Full Text] [Related]
10. Topographic and quantitative relationship between prostate inflammation, proliferative inflammatory atrophy and low-grade prostate intraepithelial neoplasia: a biopsy study in chronic prostatitis patients. Vral A; Magri V; Montanari E; Gazzano G; Gourvas V; Marras E; Perletti G Int J Oncol; 2012 Dec; 41(6):1950-8. PubMed ID: 23026863 [TBL] [Abstract][Full Text] [Related]
11. The common parasite Toxoplasma gondii induces prostatic inflammation and microglandular hyperplasia in a mouse model. Colinot DL; Garbuz T; Bosland MC; Wang L; Rice SE; Sullivan WJ; Arrizabalaga G; Jerde TJ Prostate; 2017 Jul; 77(10):1066-1075. PubMed ID: 28497488 [TBL] [Abstract][Full Text] [Related]
12. Inflammation in Prostatic Hyperplasia and Carcinoma-Basic Scientific Approach. Krušlin B; Tomas D; Džombeta T; Milković-Periša M; Ulamec M Front Oncol; 2017; 7():77. PubMed ID: 28487844 [TBL] [Abstract][Full Text] [Related]
13. [Morphogenesis of benign prostatic hyperplasia and prostatic carcinoma]. Bonkhoff H; Remberger K Pathologe; 1998 Jan; 19(1):12-20. PubMed ID: 9541938 [TBL] [Abstract][Full Text] [Related]
14. Chronic inflammatory mediators enhance prostate cancer development and progression. Thapa D; Ghosh R Biochem Pharmacol; 2015 Mar; 94(2):53-62. PubMed ID: 25593038 [TBL] [Abstract][Full Text] [Related]
15. Prostate Biopsy Markers of Inflammation are Associated with Risk of Clinical Progression of Benign Prostatic Hyperplasia: Findings from the MTOPS Study. Torkko KC; Wilson RS; Smith EE; Kusek JW; van Bokhoven A; Lucia MS J Urol; 2015 Aug; 194(2):454-61. PubMed ID: 25828974 [TBL] [Abstract][Full Text] [Related]
16. Inflammation and chronic prostatic diseases: evidence for a link? Sciarra A; Di Silverio F; Salciccia S; Autran Gomez AM; Gentilucci A; Gentile V Eur Urol; 2007 Oct; 52(4):964-72. PubMed ID: 17618043 [TBL] [Abstract][Full Text] [Related]
17. The inflammatory microenvironment and microbiome in prostate cancer development. Sfanos KS; Yegnasubramanian S; Nelson WG; De Marzo AM Nat Rev Urol; 2018 Jan; 15(1):11-24. PubMed ID: 29089606 [TBL] [Abstract][Full Text] [Related]
18. Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes. Norström MM; Rådestad E; Sundberg B; Mattsson J; Henningsohn L; Levitsky V; Uhlin M Oncotarget; 2016 Apr; 7(17):23581-93. PubMed ID: 26993768 [TBL] [Abstract][Full Text] [Related]
19. The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer. Oseni SO; Naar C; Pavlović M; Asghar W; Hartmann JX; Fields GB; Esiobu N; Kumi-Diaka J Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370720 [TBL] [Abstract][Full Text] [Related]
20. Influence of chronic inflammation on Bcl-2 and PCNA expression in prostate needle biopsy specimens. Glover M; Soni S; Ren Q; Maclennan GT; Fu P; Gupta S Oncol Lett; 2017 Oct; 14(4):3927-3934. PubMed ID: 28943900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]